{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:13:24Z","timestamp":1649171604985},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej14-0271","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T23:21:15Z","timestamp":1406244075000},"page":"967-988","source":"Crossref","is-referenced-by-count":1,"title":["Likelihood ratio-based integrated personal risk assessment of type 2 diabetes"],"prefix":"10.1507","volume":"61","author":[{"given":"Noriko","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Epigenetic Epidemiology\/ Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nay Chi","family":"Htun","sequence":"additional","affiliation":[{"name":"Department of Epigenetic Epidemiology\/ Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Daimon","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"},{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Tamiya","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Kato","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"},{"name":"Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Kubota","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Fukao","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Kayama","sequence":"additional","affiliation":[{"name":"Global Center of Excellence Program Study Group, Yamagata University School of Medicine, Yamagata 990-9585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Epigenetic Epidemiology\/ Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Imura H (2013) Life course health care and preemptive approach to non-communicable diseases. <i>Proc Jpn Acad Ser B Phys Biol Sci<\/i> 89: 462-473.","DOI":"10.2183\/pjab.89.462"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lindstr&ouml;m J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, <i>et al<\/i>. (2010) Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. <i>Horm Metab Res <\/i>42 Suppl 1: S37-55.","DOI":"10.1055\/s-0029-1240975"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, <i>et al<\/i>. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. <i>N Engl J Med<\/i> 355: 241-250.","DOI":"10.1056\/NEJMoa062418"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Imamura M, Shigemizu D, Tsunoda T, Iwata M, Maegawa H, <i>et al<\/i>. (2013) Assessing the clinical utility of a genetic risk score constructed using 49 susceptibility alleles for type 2 diabetes in a Japanese population. <i>J Clin Endocrinol Metab<\/i> 98: E1667-1673.","DOI":"10.1210\/jc.2013-1642"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bao W, Hu FB, Rong S, Rong Y, Bowers K, <i>et al<\/i>. (2013) Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review. <i>Am J Epidemiol<\/i> 178: 1197-1207.","DOI":"10.1093\/aje\/kwt123"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, <i>et al<\/i>. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. <i>N Engl J Med <\/i>359: 2220-2232.","DOI":"10.1056\/NEJMoa0801869"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Park JH, Gail MH, Weinberg CR, Carroll RJ, Chung CC, <i>et al<\/i>. (2011) Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. <i>Proc Natl Acad Sci U S A<\/i> 108: 18026-18031.","DOI":"10.1073\/pnas.1114759108"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dudley, Joel T &amp; Karczewski KJ (2013) Exploring Personal Genomics. Oxford Universiy Press.","DOI":"10.1093\/acprof:oso\/9780199644483.001.0001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, <i>et al<\/i>. (2012) Personal omics profiling reveals dynamic molecular and medical phenotypes. <i>Cell<\/i> 148: 1293-1307.","DOI":"10.1016\/j.cell.2012.02.009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, <i>et al<\/i>. (2010) Clinical assessment incorporating a personal genome. <i>Lancet<\/i> 375: 1525-1535.","DOI":"10.1016\/S0140-6736(10)60452-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Morgan AA, Chen R, Butte AJ (2010) Likelihood ratios for genome medicine. <i>Genome Med<\/i> 2: 30.","DOI":"10.1186\/gm151"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen R, Corona E, Sikora M, Dudley JT, Morgan AA, <i>et al<\/i>. (2012) Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. <i>PLoS Genet<\/i> 8: e1002621.","DOI":"10.1371\/journal.pgen.1002621"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gupta R, Ratan A, Rajesh C, Chen R, Kim HL, <i>et al<\/i>. (2012) Sequencing and analysis of a South Asian-Indian personal genome. <i>BMC Genomics<\/i> 13: 440.","DOI":"10.1186\/1471-2164-13-440"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kato N (2012) Ethnic diversity in type 2 diabetes genetics between East Asians and Europeans. <i>J Diabetes Investig<\/i> 3: 349-351.","DOI":"10.1111\/j.2040-1124.2012.00222.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hara K, Fujita H, Johnson TA, Yamauchi T, Yasuda K, <i>et al<\/i>. (2014) Genome-Wide Association Study Identifies Three Novel Loci for Type 2 Diabetes. <i>Hum Mol Genet <\/i>23: 239-246.","DOI":"10.1093\/hmg\/ddt399"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Boffetta P, McLerran D, Chen Y, Inoue M, Sinha R, <i>et al<\/i>. (2011) Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. <i>PloS One<\/i> 6: e19930.","DOI":"10.1371\/journal.pone.0019930"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saito I, Kokubo Y, Yamagishi K, Iso H, Inoue M, <i>et al<\/i>. (2011) Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study. <i>Atherosclerosis<\/i> 216: 187-191.","DOI":"10.1016\/j.atherosclerosis.2011.01.021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Heianza Y, Arase Y, Saito K, Hsieh SD, Tsuji H, <i>et al<\/i>. (2013) Development of a screening score for undiagnosed diabetes and its application in estimating absolute risk of future type 2 diabetes in Japan: Toranomon Hospital Health Management Center Study 10 (TOPICS 10). <i>J Clin Endocrinol Metab<\/i> 98: 1051-1060.","DOI":"10.1210\/jc.2012-3092"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Salanti G, Southam L, Altshuler D, Ardlie K, Barroso I, <i>et al<\/i>. (2009) Underlying genetic models of inheritance in established type 2 diabetes associations. <i>Am J Epidemiol<\/i> 170: 537-545.","DOI":"10.1093\/aje\/kwp145"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2005) The choice of a genetic model in the meta-analysis of molecular association studies. <i>Int J Epidemiol <\/i>34: 1319-1328.","DOI":"10.1093\/ije\/dyi169"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, <i>et al<\/i>.(2012) A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population. <i>PLoS One <\/i>7: e46263.","DOI":"10.1371\/journal.pone.0046263"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. <i>Lancet<\/i> 380: 601-610.","DOI":"10.1016\/S0140-6736(12)60987-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hayashi T, Tsumura K, Suematsu C, Endo G, Fujii S, <i>et al<\/i>. (1999) High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. <i>Diabetes Care<\/i> 22: 1683-1687.","DOI":"10.2337\/diacare.22.10.1683"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Medalie JH, Papier CM, Goldbourt U, Herman JB (1975) Major Factors in the Development of Diabetes Mellitus in 10,000 men. <i>Arch Intern Med<\/i> 135: 811-817.","DOI":"10.1001\/archinte.1975.00330060055007"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ (2007) Blood pressure and risk of developing type 2 diabetes mellitus: the Women&rsquo;s Health Study. <i>Eur Heart J <\/i>28: 2937-2943.","DOI":"10.1093\/eurheartj\/ehm400"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Golden SH, Wang NY, Klag MJ, Meoni LA, Brancati FL (2003) Blood pressure in young adulthood and the risk of type 2 diabetes in middle age. <i>Diabetes Care<\/i> 26: 1110-1115.","DOI":"10.2337\/diacare.26.4.1110"},{"key":"27","unstructured":"27. Morimoto A, Nishimura R, Tajima N (2010) Trends in the Epidemiology of Patients with Diabetes in Japan. <i>JMAJ <\/i>53: 36-40."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: visualizing classifier performance in R. <i>Bioinformatics<\/i> 21: 3940-3941.","DOI":"10.1093\/bioinformatics\/bti623"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Heianza Y, Hara S, Arase Y, Saito K, Tsuji H, <i>et al<\/i>. (2012) Impact of introducing HbA1c into the diagnostic criteria on prevalence and cardiovascular risk profiles of individuals with newly diagnosed diabetes in Japan: the Toranomon Hospital Health Management Center Study 2 (TOPICS 2). <i>Diabetes Res Clin Pract <\/i>95: 283-290.","DOI":"10.1016\/j.diabres.2011.10.024"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pottie K, Jaramillo A, Lewin G, Dickinson J, Bell N, <i>et al<\/i>. (2012) Recommendations on screening for type 2 diabetes in adults. <i>CMAJ<\/i> 184: 1687-1696.","DOI":"10.1503\/cmaj.120732"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lindstr&ouml;m J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. <i>Diabetes Care <\/i>26: 725-731.","DOI":"10.2337\/diacare.26.3.725"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Iwata M, Maeda S, Kamura Y, Takano A, Kato H, <i>et al<\/i>. (2012) Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals. <i>Diabetes Care<\/i> 35: 1763-1770.","DOI":"10.2337\/dc11-2006"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/10\/61_EJ14-0271\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:42:04Z","timestamp":1618296124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/10\/61_EJ14-0271\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0271","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}